A. Nedved

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

T. Shanafelt, S. Slager, A. Chanan-Khan, 2020, Cancer medicine.

Drug-induced neutropenia

M. Akhtari, A. Nedved, 1983, The Lancet.

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma

D. Dingli, S. Ansell, Shaji K. Kumar, 2019, Blood.

The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T‐cell therapy

S. Ansell, M. Hathcock, Yi Lin, 2021, American journal of hematology.

Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy

K. Stockerl-Goldstein, Sean R. DeFrates, Lindsay M. Hladnik, 2016, Pharmacotherapy.

Clinical Treatment Guidelines for Tafasitamab plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

G. Nowakowski, K. Maddocks, A. Nedved, 2023, The oncologist.

Successful Continuation of Clozapine in Conjunction With Chimeric Antigen Receptor T-Cell (CAR-T) Immunotherapy: Case Report.

J. Leung, Heather P. May, Jade L. Kutzke, 2020, Clinical lymphoma, myeloma & leukemia.